ABEONA THERAPEUTICS INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2019-06-30 was $78.00K, a 54.65% decline year-over-year.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2019-03-31 was $172.00K, a 0.00% change year-over-year.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2018-06-30 was $172.00K.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2018-03-31 was $172.00K.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2018 was $688.00K, a 45.91% decline from fiscal 2017.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2017 was $1.27M, a 62.94% decline from fiscal 2016.
- ABEONA THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2016 was $3.43M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2019-06-30 | $78.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $172.00K 10-Q · filed 2019-08-09 | |
| 2018-12-31 | $688.00K 10-K · filed 2019-03-18 | |
| 2018-06-30 | $172.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $172.00K 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $1.27M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $3.43M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |